Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus

Arthritis and Rheumatism

Volumn 64, Issue 8, 2012, Pages 2677-2686

  Petri, Michelle ^a   Orbai, Ana Maria ^a   Alarcõn, Graciela S ^b   Gordon, Caroline ^c   Merrill, Joan T ^d   Fortin, Paul R ^e   Bruce, Ian N ^f   Isenberg, David ^g   Wallace, Daniel J ^h   Nived, Ola ⁱ   Sturfelt, Gunnar ⁱ   Ramsey Goldman, Rosalind ^j   Bae, Sang Cheol ^k   Hanly, John G ^l   Sánchez Guerrero, Jorge ^m   Clarke, Ann ⁿ   Aranow, Cynthia ^o   Manzi, Susan ^p   Urowitz, Murray ^q   Gladman, Dafna ^q   Kalunian, Kenneth ^r   Costner, Melissa ^s   Werth, Victoria P ^t   Zoma, Asad ^u   Bernatsky, Sasha ⁿ   Ruiz Irastorza, Guillermo ^v   Khamashta, Munther A ^w   Jacobsen, Soren ^x   Buyon, Jill P ^y   Maddison, Peter ^z   Dooley, Mary Anne ^aa   Van Vollenhoven, Ronald F ^ab   Ginzler, Ellen ^ac   Stoll, Thomas ^ad   Peschken, Christine ^ae   Jorizzo, Joseph L ^af   Callen, Jeffrey P ^ag   Lim, S Sam ^ah   Fessler, Barri J ^b   Inanc, Murat ^ai   Kamen, Diane L ^aj   Rahman, Anisur ^g   Steinsson, Kristjan ^ak   Franks, Andrew G ^y   Sigler, Lisa ^a   Hameed, Suhail ^a   Fang, Hong ^a   Pham, Ngoc ^a   Brey, Robin ^al   Weisman, Michael H ^am   McGwin, Gerald ^b   Magder, Laurence S ^an   more..

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^d OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^e LAVAL UNIVERSITY   (Canada)

^f UNIVERSITY OF MANCHESTER   (United Kingdom)

^g UNIVERSITY COLLEGE LONDON   (United Kingdom)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ LUND UNIVERSITY HOSPITAL   (Sweden)

^j NORTHWESTERN UNIVERSITY   (United States)

^k Hanyang University Hospital for Rheumatic Diseases   (South Korea)

^l DALHOUSIE UNIVERSITY   (Canada)

^m UNIVERSITY HEALTH NETWORK   (Canada)

ⁿ MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^o FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^p ALLEGHENY GENERAL HOSPITAL   (United States)

^q UNIVERSITY OF TORONTO   (Canada)

^r UNIVERSITY OF CALIFORNIA   (United States)

^s North Dallas Dermatology Associates   (United States)

^t UNIVERSITY OF PENNSYLVANIA   (United States)

^u HAIRMYRES HOSPITAL   (United Kingdom)

^v HOSPITAL DE CRUCES   (Spain)

^w ST THOMAS HOSPITAL   (United Kingdom)

^x Rigshospitalet   (Denmark)

^y NEW YORK UNIVERSITY   (United States)

^z YSBYTY GWYNEDD   (United Kingdom)

^aa UNIVERSITY OF NORTH CAROLINA   (United States)

^ab KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^ac SUNY DOWNSTATE MEDICAL CENTER   (United States)

^ad Kantonsspital Schaffhausen   (Switzerland)

^ae UNIVERSITY OF MANITOBA   (Canada)

^af WAKE FOREST UNIVERSITY   (United States)

^ag UNIVERSITY OF LOUISVILLE   (United States)

^ah EMORY UNIVERSITY   (United States)

^ai ISTANBUL UNIVERSITY   (Turkey)

^aj MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^ak LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^al UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^am CEDARS SINAI MEDICAL CENTER   (United States)

^an UNIVERSITY OF MARYLAND   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CLASSIFICATION; CONTROLLED STUDY; FIBROMYALGIA; HUMAN; MAJOR CLINICAL STUDY; MYOSITIS; PRIORITY JOURNAL; PSORIASIS; RHEUMATOID ARTHRITIS; ROSACEA; SARCOIDOSIS; SCLERODERMA; SENSITIVITY AND SPECIFICITY; SJOEGREN SYNDROME; SKIN LUPUS ERYTHEMATOSUS; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC LUPUS INTERNATIONAL COLLABORATING CLINICS CLASSIFICATION CRITERION; VALIDATION PROCESS; VASCULITIS;

EID: 84864470206     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.34473     Document Type: Article

References (33)

1. Helmick CG, Felson DT, Lawrence RC, Gabriel S, Hirsch R, Kwoh CK, et al, for the National Arthritis Data Workgroup. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: part I. Arthritis Rheum 2008; 58: 15-25.
2. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfeld NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-7.
3. Hochberg MC, for the Diagnostic and Therapeutic Criteria Committee of the American College of Rheumatology. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [letter]. Arthritis Rheum 1997; 40: 1725.
4. Levin RE, Weinstein A, Peterson M, Testa MA, Rothfield NF,. A comparison of the sensitivity of the 1971 and 1982 American Rheumatism Association criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1984; 27: 530-8.
5. Passas CM, Wong RL, Peterson M, Testa MA, Rothfield NF,. A comparison of the specificity of the 1971 and 1982 American Rheumatism Association criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1985; 28: 620-3.
6. Clough JD, Elrazak M, Calabrese LH, Valenzuela R, Braun WB, Williams GW,. Weighted criteria for the diagnosis of systemic lupus erythematosus. Arch Intern Med 1984; 144: 281-5.
7. Costenbader KH, Karlson EW, Mandl LA,. Defining lupus cases for clinical studies: the Boston weighted criteria for the classification of systemic lupus erythematosus. J Rheumatol 2002; 29: 2545-50.
8. Sanchez ML, Alarcon GS, McGwin G Jr, Fessler BJ, Kimberly RP,. Can the weighted criteria improve our ability to capture a larger number of lupus patients into observational and interventional studies? A comparison with the American College of Rheumatology criteria. Lupus 2003; 12: 468-70.
9. Edworthy SM, Zatarain E, McShane DJ, Bloch DA,. Analysis of the 1982 ARA lupus criteria data set by recursive partitioning methodology: new insights to the relative merit of individual criteria. J Rheumatol 1988; 15: 1493-8.
10. Breiman L, Friedman JH, Olshen RA, Stone CG,. Classification and regression trees. Belmont: Wadsworth International Group; 1984.
11. Fries JF,. Methodology of validation of criteria for SLE. Scand J Rheumatol Suppl 1987; 65: 25-30.
12. Gladman D, Ginzler E, Goldsmith C, Fortin P, Liang M, Urowitz M, et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 1996; 39: 363-9.
13. Petri M, Magder L,. Classification criteria for systemic lupus erythematosus: a review. Lupus 2004; 13: 829-37.
14. Navarra SV, Guzman RM, Gallacher AE, Hall S, Levy RA, Jimenez RE, et al. Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial. Lancet 2011; 377: 721-31.
15. Albrecht J, Berlin JA, Braverman IM, Callen JP, Costner MI, Dutz J, et al. Dermatology position paper on the revision of the 1982 ACR criteria for systemic lupus erythematosus. Lupus 2004; 13: 839-49.
16. Zoma A,. Musculoskeletal involvement in systemic lupus erythematosus. Lupus 2004; 13: 851-3.
17. Clarke A,. Proposed modifications to 1982 ACR classification criteria for systemic lupus erythematosus: serositis criterion. Lupus 2004; 13: 855-6.
18. Dooley MA, Aranow C, Ginzler EM,. Review of ACR renal criteria in systemic lupus erythematosus. Lupus 2004; 13: 857-60.
19. Hanly JG,. ACR classification criteria for systemic lupus erythematosus: limitations and revisions to neuropsychiatric variables. Lupus 2004; 13: 861-4.
20. Kao AH, Manzi S, Ramsey-Goldman R,. Review of ACR hematologic criteria in systemic lupus erythematosus. Lupus 2004; 13: 865-8.
21. Merrill JT,. Antibodies and clinical features of the antiphospholipid syndrome as criteria for systemic lupus erythematosus. Lupus 2004; 13: 869-76.
22. Nived O, Sturfelt G,. ACR classification criteria for systemic lupus erythematosus: complement components. Lupus 2004; 13: 877-9.
23. Isenberg D,. Anti-dsDNA antibodies: still a useful criterion for patients with systemic lupus erythematosus? Lupus 2004; 13: 881-5.
24. Cohen AS, Reynolds WE, Franklin EC, Kulka JP, Ropes MW, Shulman LE, et al. Preliminary criteria for the classification of systemic lupus erythematosus. Bull Rheum Dis 1971; 21: 643-8.
25. Wright S, Filippucci E, Grassi W, Grey A, Bell A,. Hand arthritis in systemic lupus erythematosus: an ultrasound pictorial essay. Lupus 2006; 15: 501-6.
26. Christopher-Stine L, Petri M, Astor BC, Fine D,. Urine protein-to-creatinine ratio is a reliable measure of proteinuria in lupus nephritis. J Rheumatol 2004; 31: 1557-9.
27. Fine DM, Ziegenbein M, Petri M, Han EC, McKinley AM, Chellini JW, et al. A prospective study of protein excretion using short-interval timed urine collections in patients with lupus nephritis. Kidney Int 2009; 76: 1284-8.
28. ACR Ad Hoc Committee on Neuropsychiatric Lupus Nomenclature. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 1999; 42: 599-608.
29. Ainiala H, Hietaharju A, Loukkola J, Peltola J, Korpela M, Metsanoja R, et al. Validity of the new American College of Rheumatology criteria for neuropsychiatric lupus syndromes: a population-based evaluation. Arthritis Rheum 2001; 45: 419-23.
30. Reed WW, Diehl LF,. Leukopenia, neutropenia, and reduced hemoglobin levels in healthy American blacks. Arch Intern Med 1991; 151: 501-30.
31. American College of Rheumatology position statement on methodology of testing for antinuclear antibodies. 2009. URL:.
32. Mehrani T, Petri M,. Association of IgA anti-β2 glycoprotein I with clinical and laboratory manifestations of systemic lupus erythematosus. J Rheumatol 2011; 38: 64-8.
33. Weening JJ, D'Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int 2004; 65: 521-30.